This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/chemspider/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/bindingdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/pdb/
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/pubchem-compound/
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04518/identifier/drugbank/

Statements

Subject Item
n2:DB04518
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n4:DB04518 n5:DB04518
dcterms:title
3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol
adms:identifier
n9:447959 n10:46506305 n11:DB04518 n12:CK5 n13:8050 n14:394904
n6:IUPAC-Name
n7:271B6178-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B617E-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B617D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B617A-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B617B-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B617C-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B6176-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B6174-363D-11E5-9242-09173F13E4C5 n7:271B6177-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B6175-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B6184-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B6185-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B617F-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B6180-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B6182-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B6181-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B6183-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B618A-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B618C-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B618D-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B6189-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B6188-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B618B-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B6179-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B6186-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B6187-363D-11E5-9242-09173F13E4C5